Forgot your password ?

 login: 

  Why you need to be registered

 password: 

 Register 

Current issueArchivesubscribeInstructions to Authors

search by
Google





subscribe on the news  

 

Pay Color Illustration
 


Medline

PubMed, a service of the National Library of Medicine

World Oncology Network

R.E.Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology



Vol. 25, No. 1, 2003 (March)

Content

PRODUCTION OF RECOMBINANT OF hBD-2 —
HUMAN ANTIMICROBIAL PEPTIDE EXPRESSED
IN CERVICAL AND VULVAL CANCER

 

P.V. Pogribnoy*, I.L. Lisovskiy, N.V. Markeeva, V.M. Shnitsar, I.I. Zinchenko, M.A. Soldatkina

R.E. Kavetsky Institute of Experimental Pathology,
Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
Resume. For preparation of recombinant human beta defensin-2 (hBD-2), the expression of the peptide fused with GST in bacterial system was chosen. hBD-2 cDNA fragment was cloned in pGEX-2T vector and the construct was introduced into E.coli XL-Gold cells. Fusion protein was purified by affine chromatography on GST-sepharose, and underwent proteolysis with trombin. Active recombinant hBD-2 was purified from the proteolytic mixture by the ion exchange chromatography. Key words: hBD-2, cloning, expression, fusion protein.

Abstract. For preparation of recombinant human beta defensin-2 (hBD-2), the expression of the peptide fused with GST in bacterial system was chosen. hBD-2 cDNA fragment was cloned in pGEX-2T vector and the construct was introduced into E.coli XL-Gold cells. Fusion protein was purified by affine chromatography on GST-sepharose, and underwent proteolysis with trombin. Active recombinant hBD-2 was purified from the proteolytic mixture by the ion exchange chromatography.

Key Words: hBD-2, cloning, expression, fusion protein.

Language:  English

[full text]




Copyright (c) MORION 1999-2008

Current issue | Archive | subscribe | Instructions to Authors | E-Mail to webmaster